This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Valio Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Justus Reunanen: Innovator in Peptide Technology
Introduction
Justus Reunanen is a notable inventor based in Kerava, Finland. He has made significant contributions to the fields of life sciences and the food, feed, and pharmaceutical industries. His innovative work focuses on novel peptides and their applications.
Latest Patents
Justus Reunanen holds a patent for "Peptides and methods for producing them." This invention encompasses various aspects, including novel peptides, pilus structures, polynucleotides, and vectors. The patent also covers host cells, products, and pharmaceutical compositions that incorporate these elements. Furthermore, it details methods for producing peptides and pilus structures, as well as treatments aimed at screening bacterial strains. The invention is particularly relevant for reducing or inhibiting the adhesion of pathogenic bacteria and promoting the adhesion of beneficial bacterial cells to mucus. Additionally, it includes methods for detecting probiotic bacterial strains or pathogen strains. He has 1 patent to his name.
Career Highlights
Throughout his career, Justus Reunanen has worked with prominent companies such as Valio Ltd. and Chr. Hansen A/S. His experience in these organizations has allowed him to develop and refine his expertise in peptide technology and its applications in various industries.
Collaborations
Justus has collaborated with esteemed colleagues, including Willem Meindert De Vos and Airi Palva. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Justus Reunanen is a pioneering inventor whose work in peptide technology has the potential to impact various sectors significantly. His contributions to the life sciences and pharmaceutical industries highlight the importance of innovation in addressing contemporary challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
